Farther Finance Advisors, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in HALO

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$879,833

+$18,122 QoQ

Shares Held

11,241

-15.7% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#321

of 664 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. HALO ranks #4 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc. This page	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$879,833	11,241	-15.7%	Shares	Sole	2026-07-17
2026-03-31	$861,711	13,333	+7.4%	Shares	Sole	2026-04-07
2025-12-31	$835,529	12,415	+7.5%	Shares	Sole	2026-01-23
2025-09-30	$847,370	11,554	+32.5%	Shares	Sole	2025-10-14
2025-06-30	$453,718	8,722	+58.4%	Shares	Sole	2025-07-11
2025-03-31	$351,274	5,505	+620.5%	Shares	Sole	2025-04-14
2024-12-31	$36,526	764	-52.8%	Shares	Sole	2025-02-10
2024-09-30	$92,728	1,620	+173.6%	Shares	Sole	2024-10-29
2024-06-30	$30,997	592	+332.1%	Shares	Sole	2024-07-31
2024-03-31	$5,573	137	-45.8%	Shares	Sole	2024-05-14
2023-12-31	$9,350	253	+743.3%	Shares	Sole	2024-02-15
2023-09-30	$1,146	30	0.0%	Shares	Sole	2023-11-14
2023-06-30	$1,082	30	+500.0%	Shares	Sole	2024-05-14
2023-03-31	$190	5	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.